Vera Therapeutics
Signal active
Organization
Contact Information
Overview
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential. The company's gene-editing technology can potentially cure patients with sickle cell disease, cystic fibrosis, and other devastating genetic disorders, enabling physicians to improve gene detection and regulation.
About
Industries
Biotechnology, Health Care
Founded
2016
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Vera Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care sector. The company focuses on Biotechnology and has secured $33.4B in funding across 56 round(s). With a team of 51-100 employees, Vera Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Vera Therapeutics, raised $250.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
0
Lead Investors
0
Total Funding Amount
$596.4M
Details
1
Vera Therapeutics has raised a total of $596.4M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Late Stage Venture | 80.0M |
Investors
Vera Therapeutics is funded by 25 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Vera Therapeutics | - | FUNDING ROUND - Vera Therapeutics | 80.0M |
| Octagon Capital Advisors | - | FUNDING ROUND - Octagon Capital Advisors | 80.0M |
| Vera Therapeutics | - | FUNDING ROUND - Vera Therapeutics | 42.5M |
| Armentum Partners | - | FUNDING ROUND - Armentum Partners | 42.5M |
Recent Activity
There is no recent news or activity for this profile.